Neil Kumar

Chief Executive Officer

Neil Kumar (Chief Executive Officer) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in BridgeBio Pharma, Inc. (BBIO). The largest single filing was $6.0M of BBIO (80,000 sh across 8 lots, as filed), executed Apr 9.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 14 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$60.7M

shares × price, as filed

Last traded

Sep 17

Filed yesterday

Median ADV $293.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $107.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 15 filings

Sector per market data · by filing · past 12 months

Most traded names

BBIO

BridgeBio Pharma, Inc. BBIO · 0 buys · 25 sells 25 filings

Recent filings

BBIOSALE BridgeBio Pharma, Inc. View filing → $602K
8,721 sh × $69.01
Exec Sep 17
Filed Sep 21 · 6:21 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $3.7M
44,880 sh across 6 lots
Exec Aug 18
Filed Aug 20 · 4:31 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $5.2M
76,242 sh across 10 lots
Exec Jun 4
Filed Jun 8 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $1.8M
25,303 sh across 4 lots
Exec May 21
Filed May 26 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $5.2M
77,201 sh across 8 lots
Exec May 7
Filed May 11 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $6.0M
80,000 sh across 8 lots
Exec Apr 9
Filed Apr 13 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $5.5M
79,400 sh across 8 lots
Exec Mar 12
Filed Mar 16 · 5:30 PM ET BBIOSALE BridgeBio Pharma, Inc. View filing → $2.0M
27,451 sh across 2 lots
Exec Feb 19
Filed Feb 23 · 5:30 PM ET More filings →